Matti A. Rookus - Concepedia

Author

Matti A. Rookus

Also Known As

Allan Spigelman, Antje Seidel-Renkert, Antoniou, Antonis C., Arjen R. Mensenkamp, Carol Chu, Christi J van Asperen, Douglas F Easton, Douglas F. Easton, Flora E. Van Leeuwen, Flora E. van Leeuwen

248

Publications

12.4K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Radboud University Nijmegen Leiden University Medical Center University Medical Center Utrecht

About

Matti A. Rookus is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.2K
2	Health Sciences	4	4	260
3	Public Health	4	4	494
4	Nursing	1	1	116
5	Cell Biology	1	1	42

Matti A. Rookus

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Karoline Kuchenbaecker, John L. Hopper, Daniel R. Barnes, JAMA	2017	2.7K
Decrease in Mortality in Lynch Syndrome Families Because of Surveillance Andrea E. van der Meulen‐de Jong, Yvonne Hendriks, Jan H. Kleibeuker, Gastroenterology Lynch Syndrome FamiliesGenetic EpidemiologyEpidemiologyPublic Health	2006	293
Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers T.C. van Sprundel, Marjanka K. Schmidt, Matti A. Rookus, British Journal of Cancer Surgical OncologyBrca2 Mutation CarriersContralateral Prophylactic MastectomyBreast OncologyMedicine	2005	288
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK) Anouk Pijpe, Nadine Andrieu, D. F. Easton, BMJ	2012	231
Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) Nadine Andrieu, David E. Goldgar, Douglas F. Easton, JNCI Journal of the National Cancer Institute	2006	231
Physical Activity and Breast Cancer Risk in Women Aged 20-54 Years Janneke Verloop, Matti A. Rookus, K van der Kooy, JNCI Journal of the National Cancer Institute	2000	213
Improved overall survival after contralateral risk‐reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis B.A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs, International Journal of Cancer Surgical OncologyBreast OncologyCancer EpidemiologyOverall SurvivalPbc Diagnosis	2014	208
Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction B.A.M. Heemskerk-Gerritsen, Caroline Seynaeve, C. J. van Asperen, JNCI Journal of the National Cancer Institute	2015	202
Effect of Chest X-Rays on the Risk of Breast Cancer Among <i>BRCA1/2</i> Mutation Carriers in the International <i>BRCA1/2</i> Carrier Cohort Study: A Report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group Nadine Andrieu, Douglas F. Easton, Jenny Chang‐Claude, Journal of Clinical Oncology	2006	188
Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog, Cancer Research	2010	184

Page 1